Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion

Kazuyuki Kumagai,1 Nobuchika Ogino,2 Marie Fukami,1 Mariko Furukawa1 1Kami-iida Daiichi General Hospital, Nagoya, Aichi, Japan; 2Shinjo Ophthalmologic Institute, Miyazaki, Japan Purpose: The purpose of this study was to determine the long-term outcomes of intravitreal bevacizumab (IVB) or intravit...

Full description

Bibliographic Details
Main Authors: Kumagai K, Ogino N, Fukami M, Furukawa M
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Clinical Ophthalmology
Subjects:
branch retinal vein occlusion
bevacizumab
tissue plasminogen activator
vitrectomy
macular edema
Online Access:https://www.dovepress.com/long-term-outcomes-of-intravitreous-bevacizumab-or-tissue-plasminogen--peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/long-term-outcomes-of-intravitreous-bevacizumab-or-tissue-plasminogen--peer-reviewed-article-OPTH

Similar Items